Clinical and Molecular Hepatology,
Год журнала:
2025,
Номер
unknown
Опубликована: Янв. 22, 2025
The
role
of
the
gut
microbiome
in
development
and
progression
liver
cancer
has
long
been
recognized.However,
presence
microbes
tumors
that
were
previously
considered
sterile
only
recently
discovered.The
intratumor
likely
originates
from
various
sources,
including
gut,
hematogenous
spread
other
mucosal
locations,
adjacent
non-cancerous
tissues,
co-metastasis
with
tumor
cells.As
a
newly
discovered
component
microenvironment,
it
regulates
host
immune
responses,
promotes
chronic
inflammation,
modulates
metabolic
pathways,
exerts
influences
cancer.These
unique
features
offer
potential
new
biomarkers
for
prognosis
treatment
response.Exploring
complex
interactions
between
to
modulate
or
target
may
provide
avenues
treatment.This
article
provides
comprehensive
review
our
current
understanding
regarding
origins
cancer,
its
characteristics,
underlying
mechanisms
by
which
affects
cancer.Furthermore,
we
discuss
promising
clinical
implications
challenges
remain
before
this
knowledge
can
be
fully
integrated
into
practice.
Metabolites,
Год журнала:
2023,
Номер
13(7), С. 796 - 796
Опубликована: Июнь 27, 2023
Cancer
is
a
huge
challenge
for
people
worldwide.
High
reactive
oxygen
species
(ROS)
levels
are
recognized
hallmark
of
cancer
and
an
important
aspect
treatment
research.
Abnormally
elevated
ROS
often
attributable
to
alterations
in
cellular
metabolic
activities
increased
oxidative
stress,
which
affects
both
the
development
maintenance
cancer.
Moderately
high
beneficial
maintain
tumor
cell
genesis
development,
while
toxic
have
been
shown
be
force
destroying
cells.
has
become
anticancer
target
based
on
proapoptotic
effect
ROS.
Therefore,
this
review
summarizes
role
DNA
damage
apoptosis
cells
caused
by
changes
metabolism,
as
well
various
therapies
targeting
generation,
order
provide
references
generation.
Signal Transduction and Targeted Therapy,
Год журнала:
2024,
Номер
9(1)
Опубликована: Март 25, 2024
Abstract
The
innate
immune
pathway
is
receiving
increasing
attention
in
cancer
therapy.
This
ubiquitous
across
various
cell
types,
not
only
cells
but
also
adaptive
cells,
tumor
and
stromal
cells.
Agonists
targeting
the
have
shown
profound
changes
microenvironment
(TME)
improved
prognosis
preclinical
studies.
However,
to
date,
clinical
success
of
drugs
remains
limited.
Interestingly,
recent
studies
that
activation
can
paradoxically
promote
progression.
uncertainty
surrounding
therapeutic
effectiveness
targeted
for
a
critical
issue
needs
immediate
investigation.
In
this
review,
we
observe
role
demonstrates
heterogeneity,
linked
development
stage,
status,
specific
types.
We
propose
within
TME,
exhibits
multidimensional
diversity.
diversity
fundamentally
rooted
cellular
heterogeneity
manifested
as
variety
signaling
networks.
pro-tumor
effect
essentially
reflects
suppression
classical
pathways
potential
alternative
pathways.
Refining
our
understanding
tumor’s
network
employing
appropriate
strategies
enhance
ability
harness
anti-tumor
ultimately
bridge
gap
from
application.
Signal Transduction and Targeted Therapy,
Год журнала:
2024,
Номер
9(1)
Опубликована: Авг. 7, 2024
Multicellular
organisms
are
composed
of
diverse
cell
types
that
must
coordinate
their
behaviors
through
communication.
Cell-cell
communication
(CCC)
is
essential
for
growth,
development,
differentiation,
tissue
and
organ
formation,
maintenance,
physiological
regulation.
Cells
communicate
direct
contact
or
at
a
distance
using
ligand-receptor
interactions.
So
cellular
encompasses
two
processes:
signal
conduction
generation
intercellular
transmission
signals,
transduction
reception
procession
signals.
Deciphering
networks
critical
understanding
metabolism.
First,
we
comprehensively
review
the
historical
milestones
in
CCC
studies,
followed
by
detailed
description
mechanisms
molecule
importance
main
signaling
pathways
they
mediate
maintaining
biological
functions.
Then
systematically
introduce
series
human
diseases
caused
abnormalities
progress
clinical
applications.
Finally,
summarize
various
methods
monitoring
interactions,
including
imaging,
proximity-based
chemical
labeling,
mechanical
force
analysis,
downstream
analysis
strategies,
single-cell
technologies.
These
aim
to
illustrate
how
functions
depend
on
these
interactions
complexity
regulatory
regulate
crucial
processes,
homeostasis,
immune
responses
diseases.
In
addition,
this
enhances
our
processes
occur
after
cell-cell
binding,
highlighting
its
application
discovering
new
therapeutic
targets
biomarkers
related
precision
medicine.
This
collective
provides
foundation
developing
targeted
drugs
personalized
treatments.
Journal of Translational Medicine,
Год журнала:
2024,
Номер
22(1)
Опубликована: Март 20, 2024
Abstract
Regulatory
T
cells
(Tregs)
expressing
the
transcription
factor
FoxP3
are
essential
for
maintaining
immunological
balance
and
a
significant
component
of
immunosuppressive
tumor
microenvironment
(TME).
Single-cell
RNA
sequencing
(ScRNA-seq)
technology
has
shown
that
Tregs
exhibit
plasticity
functional
diversity
in
various
tumors
within
TME.
This
results
playing
dual
role
TME,
which
is
not
always
centered
around
supporting
progression
as
typically
believed.
Abundant
data
confirms
anti-tumor
activities
their
correlation
with
enhanced
patient
prognosis
specific
types
malignancies.
In
this
review,
we
summarize
potential
actions
Tregs,
including
suppressing
tumor-promoting
inflammatory
responses
boosting
immunity.
addition,
study
outlines
spatial
temporal
variations
function
to
emphasize
predictive
significance
malignancies
may
change.
It
comprehend
effects
improve
therapy
strategies.
Nature Communications,
Год журнала:
2024,
Номер
15(1)
Опубликована: Авг. 17, 2024
The
intratumor
microbiome
imbalance
in
pancreatic
cancer
promotes
a
tolerogenic
immune
response
and
triggers
immunotherapy
resistance.
Here
we
show
that
Lactobacillus
rhamnosus
GG
probiotics,
outfitted
with
gallium-polyphenol
network
(LGG@Ga-poly),
bolster
by
modulating
microbiota-immune
interactions.
Upon
oral
administration,
LGG@Ga-poly
targets
tumors
specifically,
selectively
eradicates
tumor-promoting
Proteobacteria
microbiota-derived
lipopolysaccharides
through
gallium-facilitated
disruption
of
bacterial
iron
respiration.
This
elimination
microbiota
impedes
the
activation
tumoral
Toll-like
receptors,
thus
reducing
immunosuppressive
PD-L1
interleukin-1β
expression
tumor
cells,
diminishing
immunotolerant
myeloid
populations,
improving
infiltration
cytotoxic
T
lymphocytes
tumors.
Moreover,
hampers
growth
both
preventive
therapeutic
contexts,
amplifies
antitumor
efficacy
checkpoint
blockade
preclinical
models
female
mice.
Overall,
offer
evidence
thoughtfully
designed
biomaterials
targeting
can
efficaciously
augment
for
challenging
cancer.
Metabolic
alterations,
a
hallmark
of
cancer,
enable
tumor
cells
to
adapt
their
environment
by
modulating
glucose,
lipid,
and
amino
acid
metabolism,
which
fuels
rapid
growth
contributes
treatment
resistance.
In
primary
breast
metabolic
shifts
such
as
the
Warburg
effect
enhanced
lipid
synthesis
are
closely
linked
chemotherapy
failure.
Similarly,
metastatic
lesions
often
display
distinct
profiles
that
not
only
sustain
but
also
confer
resistance
targeted
therapies
immunotherapies.
The
review
emphasizes
two
major
aspects:
mechanisms
driving
in
both
how
unique
environments
sites
further
complicate
treatment.
By
targeting
vulnerabilities
at
stages,
new
strategies
could
improve
efficacy
existing
provide
better
outcomes
for
cancer
patients.
Intratumor-resident
bacteria
represent
an
integral
component
of
the
tumor
microenvironment
(TME).
Microbial
dysbiosis,
which
refers
to
imbalance
in
bacterial
composition
and
metabolic
activities,
plays
important
role
regulating
breast
cancer
development
progression.
However,
impact
specific
intratumor-resident
on
progression
their
underlying
mechanisms
remain
elusive.
16S
rDNA
gene
sequencing
was
used
analyze
cancerous
paracancerous
tissues
from
patients.
The
mouse
models
bearing
4T1
cell
tumors
were
employed
assess
influence
colonization
growth.
Tissue
infiltration
regulatory
T
(Treg)
cells
CD8+
evaluated
through
immunohistochemistry
flow
cytometric
analysis.
Comparative
metabolite
profiling
mice
conducted
using
targeted
metabolomics.
Differential
genes
stimulated
by
analyzed
transcriptomics
validated
qPCR
assay.
We
found
that
Sphingobacterium
displayed
high
abundance
tissues.
Intra-tumoral
multivorum
(S.
multivorum)
promoted
tumor-bearing
mice.
Moreover,
S.
diminished
therapeutic
efficacy
αPD-1
mAb,
associated
with
increase
infiltration,
decrese
infiltration.
Targeted
metabolomics
revealed
a
conspicuous
reduction
propionylcarnitine
colonized
Furthermore,
combination
shown
suppress
growth
compared
alone
vivo.
Mechanistically,
secretion
chemokines
CCL20
CXCL8
cells.
secreted
into
TME
facilitated
recruitment
Treg
reduced
thus
promoting
immune
escape.
This
study
reveals
suppresses
surveillance
within
TME,
thereby